For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

Glenmark Pharmaceuticals Ltd share price was down by -0.20% from the previous closing price of ₹1,639.35. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

Glenmark Life Sciences Ltd share price was up by 4.00% from the previous closing price of ₹1,003.40. Who are peers of Glenmark Life Sciences Ltd? The peers of Glenmark Life Sciences Ltd are Sun ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 46,336.71 Crore) operating in Pharmaceuticals sector. Glenmark Pharmaceuticals Ltd. key ...

HDFC Mid-Cap Opportunities Fund (G) 1182.37 77,34,755 1.55 HDFC Mid-Cap Opportunities Fund (IDCW) 1182.37 77,34,755 1.55 HDFC Mid-Cap Opportunities Fund - Direct ...

The Indian rupee opened flat at 85.79 against the US dollar in early trade on Monday, influenced by domestic equity markets, foreign capital outflow, and crude oil prices. Jan 06, 2025 09:32 Adani ...

The Quarterly Results page of Glenmark Pharmaceuticals Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.